Central Garden & Pet Company
$39.60+$0.25 (+0.6%)
Last close · Data as of Nov 20, 2026
- Market cap
- $2.2B
- P/E
- 13.4x
- EV / EBITDA
- 7.6x
- Revenue
- $3.1B
- Net margin
- 5.2%
- ROCE
- 9.9%
Price chart
Technical chartScreen technicals →+42.5% over the last year
Daily closes.
Go deeper
Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes
Performance
Price return, before dividends, to the 20 Nov 2026 close.
- 1M
- +6.7%
- 3M
- +4.0%
- 6M
- +15.4%
- 1Y
- +42.5%
- 5Y
- +2.6%
52-week range
Day change +$0.25 (+0.6%) from $39 to $40 · Last close Nov 20, 2026
Best weekday to invest, historically
The same weekly amount in CENTA, bought on each weekday since 2021.
News & filings
What Central Garden & Pet Company filed, who traded, and what's next
How to read this
"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.
AI Summary
US StockStrengthOperating margin of 8.0% against a peer median of 7.4%.
Concerns
No concern stands out for this company on the data on file.
Prices to the 20 Nov 2026 close · Financial year: fiscal 2025
Rule-based from financial data. Not advice.
About the company
Central Garden & Pet Company produces and distributes various products for the lawn and garden, and pet supplies markets in the United States. It operates through two segments: Pet and Garden.
Read moreShow less
Central Garden & Pet Company produces and distributes various products for the lawn and garden, and pet supplies markets in the United States. It operates through two segments: Pet and Garden. The Pet segment provides dog and cat supplies, such as dog treats and chews, toys, pet beds and containment, grooming items, waste management, and training pads; supplies for aquatics, small animals, reptiles, and pet birds, including toys, enclosures, habitats, bedding, and food and supplements; products for equine and livestock; animal and household health and insect control products; aquariums and terrariums, including fixtures and stands, water conditioners and supplements, water pumps and filters, and lighting systems and accessories; and live fish and small animals, as well as outdoor cushions. This segment sells its products under the Aqueon, Cadet, Comfort Zone, Farnam, Four Paws, K&H Pet Products, Kaytee, Nylabone, and Zilla brands. Its Garden segment offers lawn and garden supplies products that include grass seed; vegetable; flower and herb packet seed; wild bird feed, bird feeders, bird houses, and other birding accessories; fertilizers; decorative products; live plants; and weed and grass, as well as other herbicides, insecticide, and pesticide products. This segment sells its lawn and garden supplies products under the Amdro, Ferry-Morse, Pennington, and Sevin brands. The company sells its products to independent distributors, big-box retailers, national and regional retail chains, eCommerce and online retailers, grocery stores, nurseries, and mass merchants. Central Garden & Pet Company was founded in 1955 and is headquartered in Walnut Creek, California.
- Sector
- Consumer Defensive
- Shares outstanding
- 62.9M
Key statistics
Screen fundamentals →Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.
Valuation
- Market cap
- $2.2B
- P/E
- 13.4x
- P/B
- 1.4x
- EV / EBITDA
- 7.6x
- EV / Sales
- 0.9x
- P/S
- 0.7x
- 52-week high
- $41.55
- 52-week low
- $27.78
Profitability
- Operating margin
- 8.0%
- Net margin
- 5.2%
- EBITDA margin
- 11.5%
- ROE
- 10.3%
- ROCE
- 9.9%
- ROA
- 4.5%
- Asset turnover
- 0.86
Growth
- RevenueFY2025, the latest fiscal year in the company's growth history.
- $3.1B
- Revenue growth, 1YFY2025, the latest fiscal year in the company's growth history.
- -2.2%
- Revenue CAGR, 3YFY2025, the latest fiscal year in the company's growth history.
- -2.1%
- Net profit growth, 1YFY2025, the latest fiscal year in the company's growth history.
- 50.8%
- Free cash flowFY2025, the latest fiscal year in the company's growth history.
- $291.1M
Solvency
- Current ratio
- 3.67
- Debt / Equity
- 0.91
- Debt / Assets
- 0.40
- CFO / Net profit
- 2.04
- Cash / Market cap
- 40.5%
Where the revenue went
Of every $100 of FY2025 revenue, $5 was left as net income.
| From | To | Amount |
|---|---|---|
| Revenue | Cost of revenue | $2.1B |
| Revenue | Gross profit | $997.3M |
| Gross profit | Selling, general and administrative | $747.3M |
| Gross profit | Operating income | $250.0M |
| Operating income | Pretax income | $216.8M |
| Operating income | Interest and other expense | $33.3M |
| Pretax income | Tax and other | $53.9M |
| Pretax income | Net income | $162.8M |
Revenue and net profit
Revenue fell 2.2% in FY2025; net profit is the dashed line.
| Date | Revenue | Net profit |
|---|---|---|
| FY2022 | $3.3B | $152.2M |
| FY2023 | $3.3B | $125.6M |
| FY2024 | $3.2B | $108.0M |
| FY2025 | $3.1B | $162.8M |
Cash flows
FY2025: $332.5M from operations, $291.1M free after investment (dashed).
| Date | Operating cash flow | Free cash flow |
|---|---|---|
| FY2022 | -$34.0M | -$149.2M |
| FY2023 | $381.6M | $327.7M |
| FY2024 | $394.9M | $351.8M |
| FY2025 | $332.5M | $291.1M |
Growth
Latest fiscal year 2025: each figure with its change over the year before.
- Revenue
- $3.1B-2.2%1Y
- EBITDA
- $359.3M+23.6%1Y
- Net profit
- $162.8M+50.8%1Y
- Cash from operations
- $332.5M-15.8%1Y
- Free cash flow
- $291.1M-17.2%1Y
- Revenue CAGR, 3Y
- -2.1%
- Net profit CAGR, 3Y
- 2.3%
| Year | Revenue | EBITDA | Net profit | FCF | ROE | Revenue growth 1Y | Net profit growth 1Y |
|---|---|---|---|---|---|---|---|
| FY2025 | $3.1B | $359.3M | $162.8M | $291.1M | 10.3% | -2.2% | +50.8% |
Monthly returns
Month-by-month returns of CENTA across the years, with the seasonal pattern.
Balance sheet
What the company owns and owes at the end of FY2025.
| Line | FY2025 |
|---|---|
| Assets | $3.6B |
| Current assets | $2.0B |
| Non-current assets | $1.6B |
| Liabilities | $2.0B |
| Current liabilities | $538.8M |
| Non-current liabilities | $1.5B |
| Equity | $1.6B |
| Paid-in capital | $571.4M |
| Retained earnings | $1.0B |
| Minority interest | $1.7M |
Market cap against peers
8 peers: same sector, nearest by size.
Peers map
Consumer Defensive companies placed by value, growth and quality; CENTA highlighted.
P/E against peers
CENTA trades at 13.4x earnings against a peer median of 17.1x (a 22% discount).
Not shown (no positive earnings and no EV / Sales): United Natural Foods, Inc.
Peer comparison
Same-sector peers by market cap, with the median.
| Company | Market cap | P/E | P/B | ROE | EV/EBITDA |
|---|---|---|---|---|---|
| Central Garden & Pet CompanyCENTAthis companyP/E ↓ discount | $2.2B | 13.4x | 1.4x | 10.3% | 7.6x |
| United Natural Foods, Inc.UNFI | $3.2B | -27.4x | 2.1x | -7.6% | 21.7x |
| The Chefs' Warehouse, Inc.CHEF | $3.2B | 43.7x | 5.2x | 12.0% | 18.0x |
| Tootsie Roll Industries, Inc.TR | $2.9B | 28.6x | 3.0x | 10.6% | 17.2x |
| Interparfums, Inc.IPAR | $2.8B | 16.9x | 3.2x | 19.1% | 9.5x |
| The Andersons, Inc.ANDE | $2.5B | 26.0x | 2.0x | 7.7% | 10.3x |
| Central Garden & Pet CompanyCENT | $2.5B | 15.2x | 1.6x | 10.3% | 8.4x |
| Freshpet, Inc.FRPT | $2.4B | 17.4x | 2.0x | 11.5% | 15.1x |
| Perdoceo Education CorporationPRDO | $2.1B | 13.4x | 2.2x | 16.4% | 8.1x |
| Peer median | — | 17.1x | 2.1x | 11.1% | 12.7x |
Year-to-date ROI
CENTA since 1 January, against earlier years.
Historical volatility
CENTA's day-to-day swings over 30, 60 and 180 days.
Financial statements
Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.
Consolidated figures in USD, fiscal years, newest first.
Operating margin by fiscal year
| Date | Operating margin |
|---|---|
| FY2022 | 7.8% |
| FY2023 | 6.4% |
| FY2024 | 5.8% |
| FY2025 | 8.0% |
| Line | FY2025 |
|---|---|
| RevenueTotal Revenue | $3.1B |
| Cost of revenueCost Of Revenue | $2.1B |
| Gross profitGross Profit | $997.3M |
| Operating expensesOperating Expense | $747.3M |
| Selling, general and administrativeSelling General And Administration | $747.3M |
| Total expensesTotal Expenses | $2.9B |
| Operating incomeOperating Income | $250.0M |
| Interest and other | |
| Pretax incomePretax Income | $216.8M |
| TaxTax Provision | $52.8M |
| Net incomeNet Income | $162.8M |
| Per share | |
| Supplementary |
| Line | FY2025 |
|---|---|
| AssetsTotal Assets | $3.6B |
| Current assetsCurrent Assets | $2.0B |
| Non-current assetsTotal Non Current Assets | $1.6B |
| LiabilitiesTotal Liabilities Net Minority Interest | $2.0B |
| Current liabilitiesCurrent Liabilities | $538.8M |
| Non-current liabilitiesTotal Non Current Liabilities Net Minority Interest | $1.5B |
| EquityTotal Equity Gross Minority Interest | $1.6B |
| Supplementary |
| Line | FY2025 |
|---|---|
| Operating cash flowOperating Cash Flow | $332.5M |
| Cash from continuing operationsCash Flow From Continuing Operating Activities | $332.5M |
| Net income, continuing operationsNet Income From Continuing Operations | $164.0M |
| Depreciation and amortisationDepreciation And Amortization | $84.9M |
| Depreciation, amortisation and depletionDepreciation Amortization Depletion | $84.9M |
| Stock-based compensationStock Based Compensation | $21.1M |
| Deferred taxDeferred Tax | -$2.1M |
| Deferred income taxDeferred Income Tax | -$2.1M |
| Operating gains and lossesOperating Gains Losses | — |
| Gain loss on sale of PP&EGain Loss On Sale Of PPE | — |
| Gain loss on sale of businessGain Loss On Sale Of Business | $0.00 |
| Asset impairmentAsset Impairment Charge | $1.0M |
| Change in working capitalChange In Working Capital | -$10.9M |
| Other non-cash itemsOther Non Cash Items | $74.5M |
| Investing cash flowInvesting Cash Flow | -$44.9M |
| Cash from continuing investingCash Flow From Continuing Investing Activities | -$44.9M |
| Capital expenditureCapital Expenditure | -$41.4M |
| Purchase of PP&EPurchase Of PPE | -$41.4M |
| Net PP&E purchases and salesNet PPE Purchase And Sale | -$41.4M |
| AcquisitionsPurchase Of Business | -$3.3M |
| DisposalsSale Of Business | $0.00 |
| Net acquisitions and disposalsNet Business Purchase And Sale | -$3.3M |
| Purchase of investmentsPurchase Of Investment | $0.00 |
| Net investment purchases and salesNet Investment Purchase And Sale | $0.00 |
| Other investing changesNet Other Investing Changes | -$150.0k |
| Financing cash flowFinancing Cash Flow | -$156.6M |
| Cash from continuing financingCash Flow From Continuing Financing Activities | -$156.6M |
| Debt issuedIssuance Of Debt | $0.00 |
| Debt repaidRepayment Of Debt | -$230.0k |
| Net debt issuedNet Issuance Payments Of Debt | -$230.0k |
| Short-term debt issuedShort Term Debt Issuance | — |
| Short-term debt repaidShort Term Debt Payments | — |
| Net short-term debt issuedNet Short Term Debt Issuance | — |
| Long-term debt issuedLong Term Debt Issuance | $0.00 |
| Long-term debt repaidLong Term Debt Payments | -$230.0k |
| Net long-term debt issuedNet Long Term Debt Issuance | -$230.0k |
| Shares issuedIssuance Of Capital Stock | $0.00 |
| Common stock issuedCommon Stock Issuance | $0.00 |
| Net common stock issuedNet Common Stock Issuance | -$155.1M |
| Common stock repurchasedCommon Stock Payments | -$155.1M |
| Share buybacksRepurchase Of Capital Stock | -$155.1M |
| Dividends paidCash Dividends Paid | — |
| Other financing chargesNet Other Financing Charges | -$1.4M |
| Interest paid (financing)Interest Paid Cff | — |
| Change in cashChanges In Cash | $131.0M |
| Effect of exchange ratesEffect Of Exchange Rate Changes | -95.0% |
| Cash at the start of the yearBeginning Cash Position | $768.4M |
| Cash at the end of the yearEnd Cash Position | $898.4M |
| Free cash flowFree Cash Flow | $291.1M |
| Supplemental |
Learn while you research
Academy chapters picked for Central Garden & Pet Company and the metrics on this page.
- 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
- 02 Cyclical vs Defensive StocksConsumer staples behave defensively across the business cycle.6 min read
- 03 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
- 04 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read